Mechanisms of actio of Poly-Plat, a novel platinum antineoplastic agent

Anticancer Research

Volumn 22, Issue 4, 2002, Pages 2167-2172

  Telgenhoff, Dale J ^a   Aggarwal, Surinder K ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cisplatin; Interleukin 2; Macrophage activation; Poly Plat

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PLATINUM DERIVATIVE; POLY[(1,2 DIAMINOCYCLOHEXANE)PLATINUM]CARBOXYAMYLOSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; SUPERNATANT; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; CISPLATIN; FIBROSARCOMA; HUMANS; INTERLEUKIN-2; MACROPHAGES; MITOSIS; ORGANOPLATINUM COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0036335421     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Interactions of the antitumour drug cisplatin with DNA in vitro and in vivo
2. Metal compounds in therapy and diagnosis
3. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin
4. Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway
5. Murine macrophage activation after cisplatin or carboplatin treatment
6. Cisplatin and carboplatin-mediated activation of murine peritoneal macrophages in vitro
7. Immune system activation by cisplatin and its analog 'poly-plat': An in vitro and in vivo study
8. Enhanced immunostimulation by novel platinum anticancer agents
9. Up-regulation of induction of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatin
10. Immune system activation by CDDP and "poly-plat"
11. Effect of recombinant bovine IL-1 and IL-2 on B cell proliferation and differentiation
12. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro
13. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages
14. Transcriptional activation of the macrophage colony-stimulating factor gene by IL-2 is associated with secretion of bioactive macrophage colony-stimulating factor protein
15. Activation of human monocyte/macrophage cyto-toxicity by IL-2/IFN gamma is linked to increased expression of an antitumor receptor
16. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma
17. X-ray studies on the interaction of the anticancer agent cis-(Pt(NH3)2cl2) to tRNAphe
18. Death substrates come alive
19. Role of glutathione, glutathione S-transferases and multidrug resistance related proteins in cisplatin sensitivity
20. BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma
21. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways
22. Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy
23. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin induced DNA damage
24. GB-21, a novel platinum complex with antitumor activity
25. Cycloplatam: A novel platinum compound exhibiting a different spectrum of anti-tumour activity to cisplatin
26. The enzyme-linked immunosorbent assay (ELISA) (theory, technique and applications)
27. Ultrastructural identification of apoptotic nuclei using the TUNEL technique
28. Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds
29. Methods of reduction of cisplatin nephrotoxicity
30. Kupffer cell activation after treatment with cisplatin and its second generation novel analogs SAP, SSP, and "poly-plat"
31. Adoptive immunotherapy for cancer
32. The development of new immunotherapies for the treatment of cancer using interleukin-2, A review